AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Net Asset Momentum
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) recorded a net asset momentum of -562.6% as of December 2025, with net assets of €-43.23 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See AEST.MED.INT.HLD.SP.ADR/3 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
AEST.MED.INT.HLD.SP.ADR/3 Net Asset Momentum (2021–2025)
This chart tracks AEST.MED.INT.HLD.SP.ADR/3's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -562.6%, with net assets of €-43.23 Million EUR as of December 2025. Read AEST.MED.INT.HLD.SP.ADR/3 (3FMA) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)
The table below shows the complete annual net asset history for AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of AEST.MED.INT.HLD.SP.ADR/3.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €-43.23 Million | €510.89 Million | €554.12 Million | ▼ -562.6% |
| 2024 | €9.35 Million | €486.22 Million | €476.88 Million | ▼ -72.2% |
| 2023 | €33.63 Million | €560.66 Million | €527.03 Million | ▲ +126.7% |
| 2022 | €-125.88 Million | €546.37 Million | €672.25 Million | ▲ +32.5% |
| 2021 | €-186.42 Million | €576.94 Million | €763.36 Million | — |